CCA
NNVC icon

Checchi Capital Advisers’s NanoViricides NNVC Stock Holding History

Checchi Capital Advisers’s Portfolio NNVC Stock Details NNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-14
Closed – – 932
2016
Q2 		$0 Hold
14
– – ﹤0.01% 1617
2016
Q1 		$1K Buy
+14
New +$543 ﹤0.01% 1564

Other funds holding NNVC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
SCA
STALEY CAPITAL ADVISERS Pittsburgh, Pennsylvania $2.57B AUM 26.96% 1-Year Est. Return
PTB
Pioneer Trust Bank Salem, Oregon $441M AUM 21.13% 1-Year Est. Return

Checchi Capital Advisers's NNVC Position: Q3 2016 in Review

Checchi Capital Advisers sold out of NanoViricides (NNVC) in Q3 2016, closing a stake of 14 shares.

Checchi Capital Advisers first reported a position in NNVC in Q1 2016 and held it in 2 quarters. The position peaked at $1K in Q1 2016. 41 funds tracked by Wall St. Rank hold NNVC as of Q3 2016.

  • Checchi Capital Advisers reported no remaining NanoViricides position as of Q3 2016 after selling out during the quarter.
  • Checchi Capital Advisers sold 14 NanoViricides shares in Q3 2016.
  • Checchi Capital Advisers first reported a position in NanoViricides in Q1 2016 and held it in 2 quarters.
  • Checchi Capital Advisers's NanoViricides position peaked at $1K in Q1 2016.
  • 41 funds tracked by Wall St. Rank held NanoViricides as of Q3 2016.

Based on Checchi Capital Advisers's 13F filing for Q3 2016, filed 10 Nov 2016.